Target intelligence / Profile preview

Gastrointestinal smooth muscle contractile apparatus

Molecular classification
Protein complex, Motor protein, Cytoskeletal protein
01

Overview

The gastrointestinal (GI) smooth muscle contractile apparatus is the fundamental mechanical assembly responsible for the movement of luminal contents through the digestive tract via peristalsis and segmentation [Sanders, 2008]. This apparatus primarily comprises thick filaments of myosin II and thin filaments of actin, along with regulatory proteins such as tropomyosin and caldesmon [Somlyo & Somlyo, 2003]. The contractile state is predominantly governed by the phosphorylation of the 20-kDa myosin light chain (MLC20), a process regulated by the opposing actions of myosin light chain kinase (MLCK) and myosin light chain phosphatase (MLCP) [He et al., 2011]. In various gastrointestinal disorders, including irritable bowel syndrome (IBS), gastroparesis, and achalasia, the regulation of this apparatus is often impaired, leading to abnormal motility patterns [Sanders, 2008; StatPearls, 2023]. Therapeutic interventions target this system either by modulating intracellular calcium levels or by influencing the signaling pathways, such as Rho-kinase or NO/cGMP, that adjust the calcium sensitivity of the contractile machinery [Somlyo & Somlyo, 2003; Grassie et al., 2011]. Understanding the molecular dynamics of this apparatus is crucial for developing targeted prokinetic or antispasmodic agents.

Other names
GI contractile machinerySmooth muscle myofilamentsActin-myosin complexGastrointestinal contractile unit
02

Mechanism of action

Regulation of myosin light chain phosphorylation and actin-myosin cross-bridge cycling through the modulation of myosin light chain kinase (MLCK) and myosin light chain phosphatase (MLCP) activities.

03

Biological functions

Muscle contractionGastrointestinal motilityPeristalsisSegmentation
04

Disease associations

Irritable bowel syndromeGastroparesisAchalasiaChronic intestinal pseudo-obstructionFunctional dyspepsia
05

Safety considerations

Systemic hypotensionGastrointestinal dysmotilityGastroesophageal refluxPotential for paralytic ileus
06

Interacting drugs

Nitroglycerin

6 more in the full profile.

07

Biomarkers

Phosphorylated myosin light chain 20 (p-MLC20)Myosin light chain kinase (MLCK) expressionMyosin phosphatase target subunit 1 (MYPT1) phosphorylation

Beyond the preview

Go deeper on Gastrointestinal smooth muscle contractile apparatus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastrointestinal smooth muscle contractile apparatus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call